CUSTOM III

Our CUSTOM III clinical trial was designed to evaluate in situ customization for long lesions and multiple lesions using an expanded range of diameters using the XTENT^® Custom NX^® DES System. Enrollment of 90 patients at 13 European centers was completed in August 2007, with patient follow up at 30 days, six months and annually for 5 years.